- Home
- REKR vs MNOV Comparison
REKR vs MNOV Comparison
Compare REKR & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REKR
- MNOV
- Stock Information
- Founded
- REKR 2017
- MNOV 2000
- Country
- REKR United States
- MNOV United States
- Employees
- REKR N/A
- MNOV N/A
- Industry
- REKR Telecommunications Equipment
- MNOV Biotechnology: Pharmaceutical Preparations
- Sector
- REKR Telecommunications
- MNOV Health Care
- Exchange
- REKR Nasdaq
- MNOV Nasdaq
- Market Cap
- REKR 79.2M
- MNOV 87.3M
- IPO Year
- REKR N/A
- MNOV 2005
- Fundamental
- Price
- REKR $0.90
- MNOV $1.83
- Analyst Decision
- REKR Buy
- MNOV
- Analyst Count
- REKR 1
- MNOV 0
- Target Price
- REKR N/A
- MNOV N/A
- AVG Volume (30 Days)
- REKR 1.1M
- MNOV 136.9K
- Earning Date
- REKR 11-14-2024
- MNOV 11-13-2024
- Dividend Yield
- REKR N/A
- MNOV N/A
- EPS Growth
- REKR N/A
- MNOV N/A
- EPS
- REKR N/A
- MNOV N/A
- Revenue
- REKR $43,817,000.00
- MNOV N/A
- Revenue This Year
- REKR $55.93
- MNOV N/A
- Revenue Next Year
- REKR $57.14
- MNOV N/A
- P/E Ratio
- REKR N/A
- MNOV N/A
- Revenue Growth
- REKR 44.46
- MNOV N/A
- 52 Week Low
- REKR $0.89
- MNOV $1.12
- 52 Week High
- REKR $3.92
- MNOV $2.55
- Technical
- Relative Strength Index (RSI)
- REKR 31.36
- MNOV 52.22
- Support Level
- REKR $1.10
- MNOV $1.49
- Resistance Level
- REKR $1.15
- MNOV $2.55
- Average True Range (ATR)
- REKR 0.07
- MNOV 0.18
- MACD
- REKR -0.01
- MNOV 0.03
- Stochastic Oscillator
- REKR 1.93
- MNOV 36.84
About REKR Rekor Systems Inc.
Rekor Systems Inc is a United States-based company. The company is engaged in providing real-time roadway intelligence through AI-driven decisions. The firm uses artificial intelligence to analyze video streams and transform them into AI-driven decisions. The company's technology and machine learning models power all solutions, including Rekor Command for transportation management, Rekor Discover for urban mobility, and Rekor Scout for public safety, and commercial use. Its geographical segments are the United States and Others, of which the majority of its revenue comes from the United States.
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.